iBio
IBIO
32 hedge funds and large institutions have $5.79M invested in iBio in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 28 → 32 (+4)
2% more capital invested
Capital invested by funds: $5.68M → $5.79M (+$109K)
1.05% less ownership
Funds ownership: 31.23% → 30.18% (-1%)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$47.5K |
| 2 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$42.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.5K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6 |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$185K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$80.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.29K |
| 4 |
Citigroup
New York
|
-$342 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$57 |
IBIO Hedge Fund Activity: Q3 2024 in Review
32 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2024, worth a combined $5.79M — up 1.9% from $5.68M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IBIO positions and 0 closed out — a net gain of 5 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Dimensional Fund Advisors, opening a new position worth an estimated $47.5K. The largest seller was ADAR1 Capital Management, cutting an estimated $185K.
- 32 institutional investors held iBio (IBIO) as of Q3 2024, up from 28 in Q2 2024.
- Funds reported $5.79M of iBio stock for Q3 2024, up 1.9% quarter-over-quarter.
- 5 funds opened new iBio positions in Q3 2024 and 0 closed out, a net change of +5 holders.
- The largest iBio buyer in Q3 2024 was Dimensional Fund Advisors, an estimated $47.5K added.
- The largest iBio seller in Q3 2024 was ADAR1 Capital Management, an estimated $185K sold.
Based on aggregated 13F filings for Q3 2024.